List of Excipients in API sumatriptan and naproxen sodium
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing sumatriptan and naproxen sodium
Detailed excipient profiles for sumatriptan and naproxen sodium
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sumatriptan and naproxen sodium drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
sumatriptan and naproxen sodium drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sumatriptan and naproxen sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
sumatriptan and naproxen sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
sumatriptan and naproxen sodium drug variants containing CROSCARMELLOSE SODIUM
sumatriptan and naproxen sodium drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
sumatriptan and naproxen sodium drug variants containing CROSPOVIDONE
sumatriptan and naproxen sodium drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE MONOHYDRATE
sumatriptan and naproxen sodium drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: FD&C BLUE NO. 2
sumatriptan and naproxen sodium drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
sumatriptan and naproxen sodium drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
sumatriptan and naproxen sodium drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
sumatriptan and naproxen sodium drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
sumatriptan and naproxen sodium drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
sumatriptan and naproxen sodium drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
sumatriptan and naproxen sodium drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
sumatriptan and naproxen sodium drug variants containing MAGNESIUM STEARATE
sumatriptan and naproxen sodium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
sumatriptan and naproxen sodium drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing MALTODEXTRIN
Excipient focus: POLYETHYLENE GLYCOL
sumatriptan and naproxen sodium drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
sumatriptan and naproxen sodium drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POVIDONE K30
sumatriptan and naproxen sodium drug variants containing POVIDONE K30
sumatriptan and naproxen sodium drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
sumatriptan and naproxen sodium drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing POVIDONE K90
Excipient focus: SILICON DIOXIDE
sumatriptan and naproxen sodium drug variants containing SILICON DIOXIDE
sumatriptan and naproxen sodium drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
sumatriptan and naproxen sodium drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CHLORIDE
sumatriptan and naproxen sodium drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
sumatriptan and naproxen sodium drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sumatriptan and naproxen sodium | 16714-891 |
| Sun Pharmaceutical Industries Inc | sumatriptan and naproxen sodium | 47335-410 |
| Innovida Phamaceutique Corporation | sumatriptan and naproxen sodium | 71800-901 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sumatriptan and naproxen sodium | 0378-8755 |
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
sumatriptan and naproxen sodium drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
sumatriptan and naproxen sodium drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sumatriptan and naproxen sodium | 65862-928 |
| >Company | >Ingredient | >NDC |
sumatriptan and naproxen sodium drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
sumatriptan and naproxen sodium drug variants containing TITANIUM DIOXIDE
sumatriptan and naproxen sodium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
